Can a MuSK‑positive myasthenia gravis patient undergo laparoscopic cholecystectomy using only spinal anesthesia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Spinal Anesthesia for Laparoscopic Cholecystectomy in MuSK-Positive Myasthenia Gravis

Yes, laparoscopic cholecystectomy can be safely performed under spinal anesthesia in a MuSK-positive myasthenia gravis patient, and this approach is actually preferable to general anesthesia given the significant respiratory risks associated with muscle relaxants and general anesthesia in this population.

Why Spinal Anesthesia is the Preferred Choice

Avoiding Muscle Relaxants is Critical

In myasthenia gravis patients, regional anesthesia is preferred to general anesthesia 1. This is particularly important because:

  • Suxamethonium is absolutely contraindicated in patients with myopathies and neuromuscular diseases 2
  • Non-depolarizing muscle relaxants show dramatically increased sensitivity in myasthenia patients, requiring 50-75% dose reduction 2
  • MuSK-positive MG patients have predominantly bulbar and respiratory symptoms, increasing aspiration and respiratory failure risk 3, 4

Evidence Supporting Spinal Anesthesia for Laparoscopic Cholecystectomy

Spinal anesthesia has been successfully used for laparoscopic cholecystectomy in multiple studies:

  • A 2023 observational study of 2,074 patients demonstrated thoracic spinal anesthesia is feasible and safe for laparoscopic cholecystectomy with 94% patient satisfaction and no neurological complications 5
  • A randomized controlled trial showed spinal anesthesia provided superior postoperative pain control compared to general anesthesia with no difference in complications or recovery 6
  • Critically, spinal anesthesia has been specifically reported successful in a myasthenia gravis patient undergoing emergency laparotomy 7

Recommended Technique

Thoracic vs. Lumbar Approach

Thoracic spinal anesthesia (T10-T11) is superior to lumbar approach for this procedure:

  • Lower doses of bupivacaine (7.5-10 mg vs. 15 mg) provide adequate anesthesia 8
  • 52% reduction in hypotension incidence with lower doses 8
  • Shorter duration of motor and sensory blockade 8
  • Better hemodynamic stability 8

Specific Protocol

Based on the evidence 5, 8:

  • Interspace: T10-T11 with 26G Quincke needle
  • Medication: Bupivacaine 0.5% heavy 7.5-10 mg (NOT 15 mg) + fentanyl 25 μg
  • Target sensory level: T3
  • Pneumoperitoneum: Low pressure CO₂ (8-12 mmHg)
  • Shoulder pain prevention: Lidocaine 1% infiltration (89% success rate) 8

Critical Perioperative Considerations

Preoperative Assessment

The 2026 European Malignant Hyperthermia Group guidelines mandate 1:

  • Comprehensive pre-anesthetic assessment to plan anesthesia and estimate risk
  • ECG and echocardiography if cardiac involvement suspected
  • Lung function tests if clinical signs of reduced respiratory capacity
  • Blood tests including electrolytes, creatine kinase, kidney/liver function

Intraoperative Management

  • Avoid benzodiazepine premedication in patients with muscle weakness 1
  • Short-acting opioids and multimodal analgesia preferred to minimize respiratory depression 1
  • Active warming if cold-induced exacerbation risk 1

Postoperative Monitoring

Intensive monitoring may be necessary 1:

  • MuSK-positive patients have higher risk of respiratory crisis 3, 4
  • Consider PACU or ICU admission for close respiratory monitoring
  • Monitor for myasthenic crisis postoperatively

Common Pitfalls to Avoid

  1. Do NOT use general anesthesia with muscle relaxants unless absolutely unavoidable—if general anesthesia is required, use propofol-remifentanil without muscle relaxants 3
  2. Do NOT use standard doses of local anesthetic—use reduced doses (7.5-10 mg bupivacaine, not 15 mg)
  3. Do NOT forget shoulder pain prophylaxis—lidocaine infiltration prevents this in 89% of cases
  4. Do NOT underestimate respiratory risk—MuSK-positive patients have prominent bulbar/respiratory involvement

Technical Success Rate

  • Single attempt success: 92% 5
  • Overall success rate: 100% (no conversions to general anesthesia required) 5, 6, 8
  • Manageable complications: hypotension 18%, bradycardia 13%, shoulder pain 6% 5

The combination of avoiding muscle relaxants, superior pain control, and proven feasibility makes spinal anesthesia the optimal choice for this patient population.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.